Raynaud's phenomenon and Bronchiectasis

Summary:

Bronchiectasis is found among people with Raynaud's phenomenon, especially for people who are male, 50-59 old.

The study analyzes which people have Bronchiectasis with Raynaud's phenomenon. It is created by eHealthMe based on reports of 12 people who have Raynaud's phenomenon from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Raynaud's phenomenon?

Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas) is found to be associated with 635 drugs and 995 conditions by eHealthMe. Check the latest studies of Raynaud's phenomenon.

What is Bronchiectasis?

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 781 drugs and 857 conditions by eHealthMe. Check the latest studies of Bronchiectasis.

On Jul, 05, 2026

12 people who have Raynaud'S Phenomenon and Bronchiectasis are studied.

Would you have Bronchiectasis when you have Raynaud's phenomenon?

Gender of people who have Raynaud'S Phenomenon and experienced Bronchiectasis *:

female: 20 %
male: 80 %

Age of people who have Raynaud'S Phenomenon and experienced Bronchiectasis *:

Common co-existing conditions for these people *:

Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 11 people, 91.67%
Interstitial Lung Disease: 11 people, 91.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Cough: 12 people, 100.00%
Pneumonia: 12 people, 100.00%
Pulmonary Function Test Decreased: 12 people, 100.00%
Oral Candidiasis (fungal infection of mouth): 11 people, 91.67%
Oesophageal Dilatation (enlarged oesophagus): 11 people, 91.67%
Nosebleed (bleeding from nose): 11 people, 91.67%
Nausea And Vomiting: 11 people, 91.67%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 11 people, 91.67%
Localised Infection (infection at the single location): 11 people, 91.67%
Osteoporosis (bones weak and more likely to break): 11 people, 91.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Bronchiectasis?

- Check whether Bronchiectasis is associated with a drug or a condition

Related publications that referenced our studies

Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .

Related studies:

Treatments, associated drugs and conditions:

Raynaud's phenomenon (9,184 reports)
Bronchiectasis (12,460 reports)

All the drugs that are associated with Bronchiectasis:

Bronchiectasis (781 drugs)

All the conditions that are associated with Bronchiectasis:

Bronchiectasis (857 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Bronchiectasis and Raynaud's phenomenon, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.